A comprehensive study analyzing over 1.1 million lung tissue-resident immune cells reveals insights into how their dysfunction may contribute to lung inflammation and autoimmune diseases like lupus, rheumatoid arthritis, and scleroderma. …
Researchers found evidence that amyotrophic lateral sclerosis (ALS) may be an autoimmune disease, showing that patients have elevated numbers of inflammatory T cells that mistakenly target a specific protein expressed in neurons. …
Researchers have identified an autoimmune response and a specific autoantigen in brain cells that could explain the higher prevalence of Parkinson’s disease in men and provide a new therapeutic target. …
People with severe asthma may benefit from therapies that block interactions between histamine-releasing factor (HRF) and immunoglobulin E (IgE) antibodies. …
A new high-resolution structure of the rabies virus glycoprotein reveals potential vaccine targets. …
Study provides the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. …
A genetic signature has been identified in memory T cells of Parkinson’s disease patients, suggesting potential therapeutic targets to stop autoimmune attacks on brain cells. …
A cocktail of two monoclonal antibodies completely protects nonhuman primates from Ebola virus and Sudan virus infections. …
Four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2, including the Delta and Omicron variants. …
Scientists have found they can dramatically improve survival of mice with cystic fibrosis through a partial bone marrow transplant. …
End of content
End of content
